These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25158305)

  • 1. Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats.
    Khan S; Jena G
    Food Chem Toxicol; 2014 Nov; 73():127-39. PubMed ID: 25158305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat.
    Khan S; Jena G; Tikoo K
    Exp Mol Pathol; 2015 Apr; 98(2):230-9. PubMed ID: 25576297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat.
    Khan S; Jena GB
    Chem Biol Interact; 2014 Apr; 213():1-12. PubMed ID: 24530320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat.
    Khan S; Jena G; Tikoo K; Kumar V
    Biochimie; 2015 Mar; 110():1-16. PubMed ID: 25572918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.
    Dong W; Jia Y; Liu X; Zhang H; Li T; Huang W; Chen X; Wang F; Sun W; Wu H
    J Endocrinol; 2017 Jan; 232(1):71-83. PubMed ID: 27799462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium butyrate ameliorates erectile dysfunction through fibrosis in a rat model of partial bladder outlet obstruction.
    Kaya-Sezginer E; Yilmaz-Oral D; Kırlangıç OF; Yilmaz S; Özen FZ; Aşan M; Gur S
    Andrology; 2022 Oct; 10(7):1441-1453. PubMed ID: 35852413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
    Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
    Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
    Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
    BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.
    Chen Y; Du J; Zhao YT; Zhang L; Lv G; Zhuang S; Qin G; Zhao TC
    Cardiovasc Diabetol; 2015 Aug; 14():99. PubMed ID: 26245924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide ameliorates renal injury in streptozotocin‑induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor‑κB pathway.
    Zhou SJ; Bai L; Lv L; Chen R; Li CJ; Liu XY; Yu DM; Yu P
    Mol Med Rep; 2014 Nov; 10(5):2587-94. PubMed ID: 25215431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor sodium butyrate decreases excessive ethanol intake in dependent animals.
    Simon-O'Brien E; Alaux-Cantin S; Warnault V; Buttolo R; Naassila M; Vilpoux C
    Addict Biol; 2015 Jul; 20(4):676-89. PubMed ID: 25041570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors.
    Sharma B; Sharma PM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):180-8. PubMed ID: 23921152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic Acid Improves Glucose Homeostasis by Increasing Beta-Cell Proliferation, Function, and Reducing its Apoptosis through HDAC Inhibition in Juvenile Diabetic Rat.
    Khan S; Jena G
    J Biochem Mol Toxicol; 2016 Sep; 30(9):438-46. PubMed ID: 27079868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructure characterization of pancreatic β-cells is accompanied by modulatory effects of the HDAC inhibitor sodium butyrate on the PI3/AKT insulin signaling pathway in juvenile diabetic rats.
    Elgamal DA; Abou-Elghait AT; Ali AY; Ali M; Bakr MH
    Mol Cell Endocrinol; 2020 Mar; 503():110700. PubMed ID: 31904405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of enalapril in streptozotocin-induced diabetic rat: studies of DNA damage, apoptosis and expression of CCN2 in the heart, kidney and liver.
    Kushwaha S; Vikram A; Jena GB
    J Appl Toxicol; 2012 Sep; 32(9):662-72. PubMed ID: 21416479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress.
    Hu Y; Liu J; Yuan Y; Chen J; Cheng S; Wang H; Xu Y
    Environ Toxicol Pharmacol; 2018 Dec; 64():112-121. PubMed ID: 30342372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
    Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats.
    Surse VM; Gupta J; Tikoo K
    J Mol Endocrinol; 2011 Jun; 46(3):245-54. PubMed ID: 21450970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.